Antiparkinsonian medication masks motor signal progression in de novo patients

Antiparkinsonian medication masks motor signal progression in de novo patients

<p>Patients not yet receiving medication provide insight to drug-naïve early physiology of Parkinson's Disease (PD). Wearable sensors can measure changes in motor features before and after introduction of antiparkinsonian medication. We aimed to identify features of upper limb br...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Brzezicki, MA, Conway, N, Sotirakis, C, FitzGerald, JJ, Antoniades, CA
Format:	Journal article
Sprog:	English
Udgivet:	Cell Prss 2023

Lignende værker

Antiparkinsonian medication masks motor signal progression in de novo patients
af: Maksymilian A. Brzezicki, et al.
Udgivet: (2023-06-01)

Identification of motor progression in Parkinson's disease using wearable sensors and machine learning
af: Sotirakis, C, et al.
Udgivet: (2023)

Predicting future fallers in Parkinson’s disease using kinematic data over a period of 5 years
af: Sotirakis, C, et al.
Udgivet: (2024)

Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning
af: Charalampos Sotirakis, et al.
Udgivet: (2023-10-01)

Strategy adherence: a specific and rapidly progressive deficit in progressive supranuclear palsy
af: Brzezicki, MA, et al.
Udgivet: (2021)

Longitudinal monitoring of progressive supranuclear palsy using body-worn movement sensors
af: Sotirakis, C, et al.
Udgivet: (2022)

Predicting future fallers in Parkinson’s disease using kinematic data over a period of 5 years
af: Charalampos Sotirakis, et al.
Udgivet: (2024-12-01)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
af: Pereira, MF, et al.
Udgivet: (2022)

Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning
af: De Vos, M, et al.
Udgivet: (2020)

Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches
af: Bredemeyer, O, et al.
Udgivet: (2022)

Amantadine: an antiviral and antiparkinsonian agent
af: J. Staničová, et al.
Udgivet: (2001-09-01)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
af: T. L. Pitcher, et al.
Udgivet: (2014-01-01)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
af: Sara Silva, et al.
Udgivet: (2021-04-01)

Drug utilization study of antiparkinsonian medication in Romania during 25 years
af: Camelia Bucsa, et al.
Udgivet: (2025-02-01)

Parkinson's disease deficits in time perception to auditory as well as visual stimuli - A large online study
af: Su, ZH, et al.
Udgivet: (2022)

Quantifying motor impairment in movement disorders
af: FitzGerald, J, et al.
Udgivet: (2018)

Deciphering the actions of antiparkinsonian and antipsychotic drugs on cAMP/DARPP-32 signaling
af: Gilberto eFisone, et al.
Udgivet: (2011-07-01)

PHARMACOKINETIC STUDIES OF NEW ANTIPARKINSONIAN DRUG RAPITALAM
af: Natalya Avdeeva, et al.
Udgivet: (2016-12-01)

In vitro neuroprotective effects of dua-acting antiparkinsonians
af: Vera Silva, et al.
Udgivet: (2022-04-01)

Quantifying Motor Impairment in Movement Disorders
af: James J. FitzGerald, et al.
Udgivet: (2018-04-01)

Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication
af: Carsten Buhmann, et al.
Udgivet: (2004-02-01)

Efficacy of antiparkinsonian therapy in tremor correction according to tremorography
af: V. A. Bogacheva, et al.
Udgivet: (2024-04-01)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
af: Nicola Paccione, et al.
Udgivet: (2022-12-01)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
af: Caio M. Massari, et al.
Udgivet: (2017-10-01)

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson’s Disease in Response to Antiparkinsonian Drugs
af: Soutarou Taguchi, et al.
Udgivet: (2019-01-01)

Novel cognitive markers for early diagnosis and monitoring of progressive supranuclear palsy
af: Brzezicki, M, et al.
Udgivet: (2021)

Experimental pharmacokinetics of a new antiparkinsonian drug ADK-1113
af: O. Yu. Kravtsova, et al.
Udgivet: (2024-06-01)

Disulfide bridge-targeted metabolome mining unravels an antiparkinsonian peptide
af: Zhiwu Tong, et al.
Udgivet: (2024-02-01)

Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models
af: Carine Coneglian de Farias, et al.
Udgivet: (2014-12-01)

Antiparkinsonian effect of dicholine succinate on the model of MPTP-induced parkinsonism
af: A. K. Sariev, et al.
Udgivet: (2017-02-01)

Eye movements and deep brain stimulation
af: FitzGerald, J, et al.
Udgivet: (2016)

Using saccadometry with deep brain stimulation to study normal and pathological brain function
af: Antoniades, C, et al.
Udgivet: (2016)

High resolution photon counting CT permits direct visualisation of directional deep brain stimulation lead segments and markers
af: Manfield, J, et al.
Udgivet: (2023)

Antiparkinsonian activity of selective MAO-B inhibitors of different chemical structures
af: Vladimir N. Fedorov, et al.
Udgivet: (2024-12-01)

Objectivization of efficiency of antiparkinsonian drug administration in correction of different types of tremor
af: D. V. Zakharov, et al.
Udgivet: (2018-07-01)

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
af: Soutarou Taguchi, et al.
Udgivet: (2021-01-01)

A novel machine learning based framework for developing composite digital biomarkers of disease progression
af: Zhai, S, et al.
Udgivet: (2025)

Development of marked striatal hand with antiparkinsonian medication withdrawal during traditional (Ayurvedic) medicine treatment for Parkinson's disease
af: Lim, Shen-Yang, et al.
Udgivet: (2010)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
af: Marko Bogdanovic, et al.
Udgivet: (2022-04-01)

Impact of Duration of Parkinsonism and Antiparkinsonian Drugs on Coagulation Parameters in Patients with Parkinson’s Disease
af: Varun Kodam, et al.
Udgivet: (2024-10-01)